TITLE

New malaria combination cheaper and easier to take

AUTHOR(S)
Sibbald, Barbara
PUB. DATE
June 2005
SOURCE
CMAJ: Canadian Medical Association Journal;6/7/2005, Vol. 172 Issue 12, p1545
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Deals with the antimalaria formulation developed by the Drugs for Neglected Disease initiative to be available in 2006. Advantage of the drug over other antimalarials; Organizations that support the drug; Drug company to manufacture the antimalaria.
ACCESSION #
17149949

 

Related Articles

  • Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. Plowe, Christopher V.; Kublin, James G.; Dzinjalamala, Fraction K.; Kamwendo, Deborah S.; Mukadam, Rabia A. G.; Chimpeni, Phillips; Molyneux, Malcolm E.; Taylor, Terrie E. // BMJ: British Medical Journal (International Edition);3/6/2004, Vol. 328 Issue 7439, p545 

    Objective: To measure the efficacy of sulfadoxine-pyrimethamine treatment of falciparum malaria in Malawi from 1998 to 2002, after a change from chloroquine to sulfadoxine-pyrimethamine as first line treatment in that country in 1993. Design: Prospective open label drug efficacy study. Setting:...

  • One day treatment is as effective as seven to eradicate H pylori.  // BMJ: British Medical Journal (International Edition);3/13/2004, Vol. 328 Issue 7440, p592 

    Discusses whether a one day treatment of Helicobacter pylori is as effective as a seven day regimen in patients with dyspepsia. Rates of treatment success; Treatment side effects.

  • Treatment of severe malaria. Warrell, D. A. // Journal of the Royal Society of Medicine (Supplement);Jul1989, Vol. 82 Issue 17, p44 

    In the treatment of severe Plasmodium falciparum infection antimalarial drugs should, ideally, be given by controlled rate intravenous infusion until the patient is able to swallow tablets. In cases where infection has been acquired in a chloroquine resistant area, and where it has broken...

  • Global fund changes tack on malaria therapy. Butler, Declan // Nature;6/10/2004, Vol. 429 Issue 6992, p588 

    Reports on a move to switch malaria treatment in African to a more effective therapy. Agreement of the Geneva-based Global Fund to Fight Aids, Tuberculosis and Malaria to instruct African countries to modify all malaria agents awarded to specify only the newer drug; Resistance of the malaria...

  • Antimalarial treatment with artemisinin combination therapy in Africa. Malenga, Grace; Palmer, Ayo; Staedke, Sarah; Kazadi, Walter; Mutabingwa, Thonest; Ansah, Evelyn; Barnes, Karen I.; Whitty, Christopher J. M. // BMJ: British Medical Journal (International Edition);10/1/2005, Vol. 331 Issue 7519, p706 

    Presents an editorial regarding antimalarial treatment with artemisinin combination therapy in Africa. Increase of drug resistant malaria across Africa; Report that combination therapies are now seen to be the best solution for treating malaria; Effectiveness of artemisinin based drug...

  • Commentary. Victor, Gary // Evidence Based Medicine;Apr2006, Vol. 11 Issue 2, p52 

    The article presents comments on a study on the effectiveness of parenteral artesunate and parenteral quinine for patients with severe falciparum malaria. Parasitaemia is cleared more rapidly by artemisinin more rapidly than quinine although several clinical trials did not find any difference in...

  • In vitro antiplasmodial and cytotoxic properties of some medicinal plants from western Burkina Faso. Sanon, Souleymane; Gansane, Adama; Ouattara, Lamoussa P.; Traore, Abdoulaye; Ouedraogo, Issa N.; Tiono, Alfred; Taramelli, Donatella; Basilico, Nicoletta; Sirima, Sodiomon B. // African Journal of Laboratory Medicine;2013, Vol. 2 Issue 1, p1 

    Background: Resistance of malaria parasites to existing drugs complicates treatment, but an antimalarial vaccine that could protect against this disease is not yet available. It is therefore necessary to find new effective and affordable medicines. Medicinal plants could be a potential source of...

  • IN VITRO ANTIPLASMODIAL ACTIVITY OF COUMARIN 8-HYDROXYISOCAPNOLACTONE-2?,3?-DIOL ISOLATED FROM Micromelum minutum (G. Forst.) Wight & Arn. Susidarti, Ratna Asmah; Mustofa; Lusika, Vivanty Pemi; Astana, Yoseph Novi // Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia;2014, Vol. 25 Issue 1, p44 

    Malaria remains a health problem in tropical and subtropical countries. The spread of antimalarial resistant parasites has prompted the research to find more effective new antimalarials. One strategy to discover new antimalarial drugs is through the exploration of medicinal plants traditionally...

  • Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Dae-Kyun Ro; Paradise, Eric M.; Ouellet, Mario; Fisher, Karl J.; Newman, Karyn L.; Ndungu, John M.; Ho, Kimberly A.; Eachus, Rachel A.; Ham, Timothy S.; Kirby, James; Chang, Michelle C. Y.; Withers, Sydnor T.; Shiba, Yoichiro; Sarpong, Richmond; Keasling, Jay D. // Nature;4/13/2006, Vol. 440 Issue 7086, p940 

    Malaria is a global health problem that threatens 300–500 million people and kills more than one million people annually. Disease control is hampered by the occurrence of multi-drug-resistant strains of the malaria parasite Plasmodium falciparum. Synthetic antimalarial drugs and malarial...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics